Complete Filing Data
Immunovant, Inc. reported Stockholders Equity of $362.49 million for FY2023.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Immunovant, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income Loss | -$413.8M | -$259.3M | -$211.0M | -$156.7M | -$107.4M | -$66.4M | -$28.6M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$449.0K | $1.1M | $448.0K | $702.0K | -$282.0K | -$362.0K | |
| Operating Expenses | $438.2M | $282.7M | $218.3M | $156.0M | $108.1M | $66.1M | $28.4M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$449.0K | $1.1M | $448.0K | $702.0K | -$282.0K | -$362.0K | $185.0K |
| General And Administrative Expense | $77.2M | $57.3M | $48.0M | $54.2M | $39.5M | $18.2M | $2.7M |
| Comprehensive Income Net Of Tax | -$414.3M | -$258.3M | -$210.5M | -$156.0M | -$107.7M | -$66.8M | -$28.4M |
| Income Tax Expense Benefit | $891.0K | $567.0K | $9.0K | -$84.0K | -$358.0K | $97.0K | $19.0K |
| Other Nonoperating Income Expense | $471.0K | -$1.0M | -$253.0K | -$781.0K | $328.0K | $412.0K | -$155.0K |
| Other Comprehensive Income Loss Net Of Tax | $1.1M | $448.0K | $702.0K | -$282.0K | -$362.0K | $185.0K | |
| Research And Development Expense | $101.8M | $68.6M | $47.9M | $25.7M | |||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$107.8M | -$66.3M | -$28.6M | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$412.9M | -$258.8M | -$211.0M | -$156.8M | -$107.8M | ||
| Research And Development Expense Excluding Acquired In Process Cost | $360.9M | $212.9M | $160.3M | $101.8M | |||
| Income Taxes Paid | $1.2M | $509.0K | $0.00 | $0.00 | $166.0K | $61.0K | $68.0K |
| Income Taxes Receivable | $427.0K | $166.0K | $185.0K | $632.0K | $548.0K | $36.0K | $49.0K |
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $0.00 | $12.5M | $10.0M | ||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$449.0K | $1.1M | $448.0K | ||||
| Interest Income Expense Nonoperating Net | $24.7M | $24.9M | $7.6M | ||||
| Interest Expense | $0.00 | $625.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$110.6M | -$126.5M | -$120.6M | -$111.1M | -$109.1M | -$87.2M | -$51.4M | -$58.7M | -$73.9M | -$63.2M | -$47.9M | -$40.4M | -$41.4M | -$37.7M | -$30.5M | -$31.8M | -$20.8M | -$26.7M | -$11.3M | -$14.5M | -$20.1M | -$450.00 | -$8.8M | -$6.4M | -$4.4M |
| Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax | -$253.0K | -$287.0K | $278.0K | $569.0K | $90.0K | -$88.0K | -$1.1M | -$69.0K | -$270.0K | $2.6M | -$974.0K | -$667.0K | -$23.0K | $169.0K | $571.0K | $689.0K | -$232.0K | $26.0K | -$149.0K | -$53.0K | -$291.0K | -$62.0K | $106.0K | $35.0K | |
| Operating Expenses | $114.4M | $131.8M | $127.2M | $114.3M | $115.7M | $94.3M | $61.6M | $61.8M | $78.5M | $64.0M | $49.6M | $40.4M | $41.3M | $37.7M | $29.9M | $31.6M | $21.0M | $26.6M | $11.0M | $14.5M | $20.1M | $8.9M | |||
| Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent | -$253.0K | -$287.0K | $278.0K | $569.0K | $90.0K | -$88.0K | -$1.1M | $69.0K | $270.0K | $2.6M | -$974.0K | -$667.0K | -$23.0K | $169.0K | $571.0K | $689.0K | -$232.0K | $26.0K | -$149.0K | -$53.0K | -$291.0K | -$62.0K | |||
| General And Administrative Expense | $15.4M | $17.5M | $26.0M | $19.8M | $18.5M | $18.8M | $13.2M | $13.8M | $15.4M | $11.8M | $11.9M | $11.9M | $11.5M | $16.3M | $11.2M | $10.5M | $9.0M | $9.7M | $6.1M | $4.2M | $1.6M | $1.2M | |||
| Comprehensive Income Net Of Tax | -$110.9M | -$126.8M | -$120.3M | -$110.6M | -$109.0M | -$87.2M | -$52.5M | -$58.6M | -$73.7M | -$60.6M | -$48.9M | -$41.0M | -$41.4M | -$37.5M | -$29.9M | -$31.1M | -$21.0M | -$26.7M | -$11.4M | -$14.5M | -$20.4M | -$8.9M | |||
| Income Tax Expense Benefit | $1.6M | $594.0K | $913.0K | $152.0K | $78.0K | $77.0K | -$108.0K | $454.0K | -$11.0K | $387.0K | $261.0K | $352.0K | $0.00 | -$31.0K | -$41.0K | -$367.0K | $40.0K | $48.0K | $100.0K | $33.0K | $23.0K | $8.0K | |||
| Other Nonoperating Income Expense | -$54.0K | $250.0K | $1.2M | -$1.3M | $629.0K | $28.0K | $1.1M | $20.0K | $464.0K | -$1.8M | $793.0K | $354.0K | -$114.0K | -$84.0K | -$626.0K | -$503.0K | $225.0K | -$74.0K | $221.0K | $294.0K | $25.0K | $43.0K | |||
| Other Comprehensive Income Loss Net Of Tax | -$1.1M | $69.0K | $270.0K | $2.6M | -$974.0K | -$667.0K | -$23.0K | $169.0K | $571.0K | $689.0K | -$232.0K | $26.0K | -$149.0K | -$53.0K | -$291.0K | -$62.0K | |||||||||
| Research And Development Expense | $37.7M | $28.4M | $29.8M | $21.4M | $18.7M | $21.1M | $12.0M | $16.9M | $5.0M | $10.3M | $18.5M | $7.7M | |||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | -$30.5M | -$32.1M | -$20.7M | -$26.7M | -$11.2M | -$14.4M | -$20.0M | -$8.8M | |||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$109.1M | -$125.9M | -$119.7M | -$111.0M | -$109.0M | -$87.1M | -$51.5M | -$58.2M | -$73.9M | -$62.8M | -$47.7M | -$40.0M | -$41.4M | -$37.7M | -$30.5M | -$32.1M | -$20.7M | ||||||||
| Research And Development Expense Excluding Acquired In Process Cost | $98.9M | $114.2M | $101.2M | $94.5M | $97.3M | $75.5M | $48.3M | $48.0M | $50.6M | $42.3M | $37.7M | $28.4M | $29.8M | ||||||||||||
| Income Taxes Paid | |||||||||||||||||||||||||
| Income Taxes Receivable | $481.0K | $40.0K | $24.0K | ||||||||||||||||||||||
| Research And Development Asset Acquired Other Than Through Business Combination Written Off | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $12.5M | $10.0M | $0.00 | $0.00 | ||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent | -$253.0K | -$287.0K | $278.0K | $569.0K | $90.0K | -$88.0K | -$1.1M | $69.0K | $270.0K | ||||||||||||||||
| Interest Income Expense Nonoperating Net | $5.3M | $5.6M | $6.3M | $4.6M | $6.1M | $7.2M | $8.9M | $3.6M | $4.1M | ||||||||||||||||
| Interest Expense | $0.00 | $0.00 | $376.0K | $249.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $362.5M | $469.8M | $391.5M | $94.1M | $7.3M | -$411.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $376.5M | $493.8M | $400.1M | $100.6M | $7.0M | |||
| Liabilities And Stockholders Equity | $666.4M | $405.8M | $515.6M | $412.5M | $109.4M | $13.8M | ||
| Assets | $666.4M | $405.8M | $515.6M | $412.5M | $109.4M | $13.8M | ||
| Liabilities | $48.6M | $43.3M | $45.7M | $21.0M | $15.3M | $6.5M | ||
| Assets Current | $665.8M | $404.3M | $512.9M | $409.0M | $109.1M | $12.6M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $78.6M | $258.8M | -$117.3M | $93.7M | $299.6M | $93.6M | $7.0M | |
| Retained Earnings Accumulated Deficit | -$825.7M | -$566.3M | -$355.4M | -$198.7M | -$91.2M | -$24.8M | ||
| Common Stock Value | $14.0K | $13.0K | $12.0K | $10.0K | $5.0K | $4.0K | ||
| Cash And Cash Equivalents At Carrying Value | $635.4M | $376.5M | $493.8M | $400.1M | $100.6M | $7.0M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.9M | $852.0K | $404.0K | -$298.0K | -$16.0K | $346.0K | ||
| Accrued Liabilities Current | $50.7M | $41.3M | $40.4M | $24.6M | $15.2M | $10.9M | $6.2M | |
| Accounts Payable Current | $7.2M | $1.4M | $18.6M | $2.4M | $1.2M | $206.0K | ||
| Property Plant And Equipment Net | $462.0K | $333.0K | $330.0K | $201.0K | $65.0K | $54.0K | ||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Liabilities Current | $48.6M | $43.3M | $44.5M | $18.8M | $15.3M | |||
| Operating Lease Right Of Use Asset | $98.0K | $133.0K | $1.2M | $2.3M | $3.3M | $4.2M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $133.0K | $1.1M | $1.1M | $1.1M | $933.0K | $0.00 | ||
| Operating Lease Liability Current | $98.0K | $138.0K | $1.2M | $1.1M | $1.2M | $0.00 | ||
| Accounts Receivable Net Current | $5.3M | $700.0K | $12.2M | $596.0K | ||||
| Operating Lease Liability Noncurrent | $0.00 | $47.0K | $1.2M | $2.2M | $0.00 | |||
| Purchase Of Property And Equipment In Accounts Payable | $0.00 | $9.0K | $13.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $986.1M | $519.7M | $608.5M | $707.4M | $352.6M | $449.1M | $544.7M | $617.8M | $679.3M | $251.8M | $299.9M | $414.7M | $395.7M | $436.5M | $505.1M | $536.4M | $365.5M | $414.2M | $438.4M | $267.8M | $111.9M | -$23.3M | -$12.1M | $8.0M | $2.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $994.5M | $521.9M | $598.9M | $714.0M | $374.7M | $472.9M | $560.0M | $635.4M | $690.9M | $269.9M | $330.0M | $432.6M | $405.8M | $427.2M | $527.0M | $559.0M | $379.0M | $422.0M | $444.4M | $280.3M | $123.5M | $19.0M | $4.0M | $12.1M | ||
| Liabilities And Stockholders Equity | $1.05B | $583.0M | $661.4M | $776.2M | $420.9M | $515.7M | $589.7M | $711.4M | $292.1M | $351.2M | $456.2M | $428.1M | $458.7M | $543.2M | $566.7M | $388.0M | $433.0M | $453.9M | $290.3M | $126.6M | $117.8M | $117.4M | $405.0K | |||
| Assets | $1.05B | $583.0M | $661.4M | $776.2M | $420.9M | $515.7M | $589.7M | $711.4M | $292.1M | $351.2M | $456.2M | $428.1M | $458.7M | $543.2M | $566.7M | $388.0M | $433.0M | $453.9M | $290.3M | $126.6M | $117.8M | $117.4M | $405.0K | |||
| Liabilities | $66.3M | $63.3M | $52.9M | $68.8M | $68.3M | $66.7M | $45.0M | $32.1M | $40.3M | $51.4M | $41.6M | $32.4M | $22.2M | $38.0M | $30.3M | $22.5M | $18.9M | $15.5M | $22.5M | $14.8M | $4.4M | $4.1M | $380.4K | |||
| Assets Current | $1.04B | $573.5M | $651.8M | $767.8M | $412.5M | $507.4M | $589.0M | $710.8M | $291.2M | $350.0M | $454.4M | $426.1M | $456.3M | $540.5M | $563.8M | $384.8M | $429.4M | $450.3M | $286.1M | $126.6M | $1.8M | $2.1M | $325.0K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$115.1M | -$75.4M | -$46.6M | -$66.6M | -$21.1M | $179.7M | -$3.0M | |||||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.60B | -$1.49B | -$1.36B | -$1.24B | -$1.13B | -$1.02B | -$912.8M | -$750.4M | -$698.9M | -$640.3M | -$506.9M | -$443.7M | -$395.8M | -$308.2M | -$266.8M | -$229.1M | -$170.5M | -$138.7M | -$117.9M | -$70.7M | $306.9K | $181.9K | -$448.00 | |||
| Common Stock Value | $20.0K | $17.0K | $16.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | $12.0K | $12.0K | $10.0K | $10.0K | $10.0K | $8.0K | $5.0K | $353.00 | $355.00 | $288.00 | |||
| Cash And Cash Equivalents At Carrying Value | $994.5M | $521.9M | $598.9M | $714.0M | $374.7M | $472.9M | $560.0M | $690.9M | $269.9M | $330.0M | $432.6M | $405.8M | $427.2M | $527.0M | $559.0M | $379.0M | $422.0M | $444.4M | $280.3M | $123.5M | $1.6M | $1.9M | $325.0K | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $1.2M | $1.5M | $1.7M | $1.5M | $2.5M | $1.9M | $1.8M | -$600.0K | $513.0K | $582.0K | $1.4M | -$1.2M | -$263.0K | $419.0K | $442.0K | $273.0K | $467.0K | -$222.0K | $10.0K | -$147.0K | ||||||
| Accrued Liabilities Current | $48.5M | $45.9M | $33.9M | $27.9M | $32.1M | $24.0M | $26.1M | $23.1M | $19.0M | $31.4M | $23.1M | $16.3M | $13.3M | $5.8M | $10.1M | $8.7M | $306.1K | $24.6K | $448.00 | |||||||
| Accounts Payable Current | $8.6M | $6.9M | $7.8M | $17.7M | $19.8M | $20.7M | $11.0M | $3.9M | $7.5M | $26.5M | $14.0M | $7.5M | $1.1M | $3.8M | $4.2M | $3.1M | $2.1M | $5.8M | $8.0M | $2.8M | ||||||
| Property Plant And Equipment Net | $531.0K | $632.0K | $737.0K | $844.0K | $752.0K | $671.0K | $565.0K | $376.0K | $304.0K | $325.0K | $362.0K | $312.0K | $328.0K | $250.0K | $209.0K | $193.0K | $132.0K | $136.0K | $112.0K | $49.0K | ||||||
| Common Stock No Par Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Liabilities Current | $66.3M | $63.3M | $52.9M | $68.8M | $68.3M | $66.7M | $45.0M | $32.1M | $40.3M | $51.4M | $41.3M | $31.8M | $21.2M | $36.4M | $28.4M | $20.5M | $16.5M | $12.8M | $19.5M | $337.6K | $91.1K | $300.4K | $380.4K | |||
| Operating Lease Right Of Use Asset | $22.0K | $45.0K | $66.0K | $294.0K | $589.0K | $882.0K | $1.5M | $1.7M | $2.0M | $2.5M | $2.7M | $3.0M | $3.5M | $3.5M | $4.2M | |||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $24.0K | $66.0K | $290.0K | $279.0K | $274.0K | $152.0K | ||||||||||||||||||||
| Operating Lease Liability Current | $23.0K | $47.0K | $69.0K | $306.0K | $614.0K | $919.0K | $1.2M | $1.2M | $1.2M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | $1.1M | |||||||||||
| Accounts Receivable Net Current | $1.6M | $2.0M | $1.9M | $2.1M | $2.2M | $1.9M | $2.4M | $1.0M | $1.4M | $823.0K | $704.0K | $3.8M | $13.2M | |||||||||||||
| Operating Lease Liability Noncurrent | $0.00 | $0.00 | $0.00 | $306.0K | $614.0K | $919.0K | $2.0M | $2.4M | $2.7M | $3.0M | ||||||||||||||||
| Purchase Of Property And Equipment In Accounts Payable | $19.0K | $6.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Contribution Share Based Compensation | $24.0K | $103.0K | $330.0K | $1.1M | $184.0K | $175.0K | |
| Net Cash Provided By Used In Operating Activities | -$375.9M | -$214.2M | -$188.2M | -$106.1M | -$83.3M | -$53.4M | -$28.5M |
| Net Cash Provided By Used In Financing Activities | $454.5M | $472.4M | $70.9M | $200.1M | $383.1M | $147.0M | $35.6M |
| Increase Decrease In Prepaid Expense | $27.0M | -$1.6M | $20.5M | -$2.1M | -$753.0K | $2.8M | $2.5M |
| Share Based Compensation | $49.5M | $41.1M | $32.3M | $34.2M | $18.8M | $7.0M | $1.3M |
| Increase Decrease In Accounts Payable Trade | $10.7M | $5.8M | -$17.1M | $16.3M | $1.3M | $967.0K | -$928.0K |
| Net Cash Provided By Used In Investing Activities | -$759.0K | -$360.0K | -$197.0K | -$254.0K | -$210.0K | -$31.0K | -$52.0K |
| Increase Decrease In Accrued Liabilities | $8.9M | $1.3M | $15.6M | $9.5M | $4.5M | $6.5M | $4.9M |
| Payments To Acquire Property Plant And Equipment | $759.0K | $360.0K | $197.0K | $254.0K | $210.0K | $31.0K | $52.0K |
| Payments Of Stock Issuance Costs | $319.0K | $6.0M | $272.0K | $0.00 | $1.2M | $3.1M | $521.0K |
| Proceeds From Contributed Capital | $0.00 | $129.0K | $1.1M | $1.2M | $16.1M | ||
| Stock Issued During Period Value Share Based Compensation | $4.8M | $5.7M | $657.0K | ||||
| Increase Decrease In Income Taxes Receivable | $261.0K | -$19.0K | -$461.0K | $85.0K | $512.0K | -$13.0K | $49.0K |
| Increase Decrease In Due To Related Parties Current | $255.0K | -$329.0K | $156.0K | $176.0K | $0.00 | $244.0K | $46.0K |
| Proceeds From Stock Options Exercised | $4.8M | $5.7M | $657.0K | $0.00 | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $747.0K | $993.0K | $220.0K | -$92.0K | $0.00 | ||
| Increase Decrease In Accounts Receivable | -$3.2M | $4.6M | -$11.8M | $11.6M | $596.0K | ||
| Increase Decrease In Value Added Tax Receivable | -$3.0M | $96.0K | $2.9M | ||||
| Increase Decrease In Operating Lease Liability | -$138.0K | -$1.2M | -$1.1M | -$1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Contribution Share Based Compensation | $182.0K | $172.0K | $115.0K | $3.0K | $8.0K | $12.0K | $23.0K | $28.0K | $35.0K | $50.0K | $106.0K | $132.0K | $205.0K | $692.0K | $41.0K | $54.0K | $63.0K | $82.0K | $18.0K | $35.0K | $225.0K | $481.0K | |
| Net Cash Provided By Used In Operating Activities | -$117.4M | -$76.2M | -$47.4M | -$65.8M | -$21.2M | -$13.8M | -$8.3M | -$450.00 | |||||||||||||||
| Net Cash Provided By Used In Financing Activities | $2.9M | $686.0K | $890.0K | $21.0K | $91.0K | $193.6M | $5.3M | -$176.8K | |||||||||||||||
| Increase Decrease In Prepaid Expense | -$498.0K | $1.8M | -$8.3M | $9.2M | -$3.2M | -$2.7M | -$1.6M | ||||||||||||||||
| Share Based Compensation | $18.5M | $13.5M | $10.7M | $7.7M | $3.9M | $4.0M | $572.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable Trade | -$9.4M | $3.9M | $25.0M | -$17.5M | $675.0K | $6.8M | $291.0K | ||||||||||||||||
| Net Cash Provided By Used In Investing Activities | $0.00 | -$182.0K | -$45.0K | -$42.0K | -$18.0K | -$47.0K | $0.00 | ||||||||||||||||
| Increase Decrease In Accrued Liabilities | -$7.5M | -$17.3M | -$5.5M | $1.2M | -$597.0K | $9.5M | |||||||||||||||||
| Payments To Acquire Property Plant And Equipment | $0.00 | $182.0K | $45.0K | $42.0K | $18.0K | $47.0K | $0.00 | ||||||||||||||||
| Payments Of Stock Issuance Costs | $0.00 | $602.0K | $28.0K | $176.8K | |||||||||||||||||||
| Proceeds From Contributed Capital | $0.00 | $91.0K | $164.0K | $331.0K | |||||||||||||||||||
| Stock Issued During Period Value Share Based Compensation | $21.0M | $24.6M | $2.9M | $2.5M | $730.0K | $686.0K | $3.1M | $148.0K | $890.0K | $403.0K | $21.0K | ||||||||||||
| Increase Decrease In Income Taxes Receivable | -$12.0K | -$22.0K | |||||||||||||||||||||
| Increase Decrease In Due To Related Parties Current | $0.00 | $38.0K | |||||||||||||||||||||
| Proceeds From Stock Options Exercised | $2.9M | $686.0K | $890.0K | $21.0K | $0.00 | $63.0K | $0.00 | ||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$566.0K | $335.0K | -$47.0K | -$772.0K | $0.00 | ||||||||||||||||||
| Increase Decrease In Accounts Receivable | -$129.0K | -$2.9M | $142.0K | $947.0K | $210.0K | ||||||||||||||||||
| Increase Decrease In Value Added Tax Receivable | -$3.0M | $57.0K | |||||||||||||||||||||
| Increase Decrease In Operating Lease Liability | -$69.0K | -$301.0K | -$281.0K | -$360.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$2.73 | -$1.88 | -$1.71 | -$1.43 | -$1.22 | -$1.54 | -$1.29 |
| Common Stock Shares Issued | 145.6M | 130.3M | 116.5M | 98.0M | 56.5M | 38.6M | |
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 489.1M | |
| Common Stock Shares Outstanding | 145.6M | 130.3M | 116.5M | 98.0M | 54.7M | 38.6M | |
| Weighted Average Number Of Shares Outstanding Basic | 151.6M | 138.1M | 123.1M | 109.7M | 87.8M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 151.6M | 138.1M | 123.1M | 109.7M | 87.8M | ||
| Earnings Per Share Basic | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 87.8M | 43.2M | 22.2M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.61 | -$0.73 | -$0.71 | -$0.76 | -$0.74 | -$0.60 | -$0.36 | -$0.45 | -$0.57 | -$0.49 | -$0.41 | -$0.35 | -$0.36 | -$0.35 | -$0.31 | -$0.32 | -$0.25 | -$0.38 | -$0.28 | -$0.38 | -$0.52 | $0.00 | -$0.24 | ||
| Common Stock Shares Issued | 203.3M | 174.5M | 171.1M | 170.1M | 147.2M | 146.6M | 146.2M | 145.1M | 131.4M | 130.6M | 129.3M | 116.6M | 116.5M | 115.1M | 115.0M | 98.0M | 98.0M | 97.9M | 81.8M | 56.5M | 3.5M | 3.5M | 2.9M | ||
| Common Stock Shares Authorized | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 30.0M | 30.0M | 30.0M | ||
| Common Stock Shares Outstanding | 203.3M | 174.5M | 171.1M | 170.1M | 147.2M | 146.6M | 146.2M | 145.1M | 131.4M | 130.6M | 129.3M | 116.6M | 116.5M | 115.1M | 115.0M | 98.0M | 98.0M | 97.9M | 80.9M | 54.7M | 3.5M | 3.5M | 2.9M | ||
| Weighted Average Number Of Shares Outstanding Basic | 181.5M | 173.6M | 170.9M | 146.9M | 146.5M | 146.1M | 144.5M | 131.2M | 130.5M | 128.6M | 116.6M | 116.6M | 115.0M | 109.1M | 98.0M | 97.9M | 84.4M | 70.8M | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 181.5M | 173.6M | 170.9M | 146.9M | 146.5M | 146.1M | 144.5M | 131.2M | 130.5M | 128.6M | 116.6M | 116.6M | 115.0M | 109.1M | 98.0M | 97.9M | 84.4M | 70.8M | |||||||
| Earnings Per Share Basic | $-0.61 | $-0.73 | $-0.71 | $-0.76 | $-0.74 | $-0.60 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | $-0.36 | $-0.35 | $-0.31 | $-0.32 | $-0.25 | $-0.38 | |||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 97.9M | 84.4M | 70.8M | 41.0M | 38.6M | 38.6M | 2.5M | 36.7M | |||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $49.5M | $41.0M | $32.0M | $33.1M | $18.6M | $6.8M | |
| Prepaid Expense Current | $24.9M | $26.9M | $6.3M | $7.7M | $5.5M | $2.6M | |
| Depreciation | $377.0K | $231.0K | $193.0K | $126.0K | $65.0K | $21.0K | $10.0K |
| Additional Paid In Capital | $1.44B | $928.0M | $824.8M | $590.4M | $185.3M | $31.8M | |
| Foreign Currency Transaction Gain Loss Unrealized | |||||||
| Stock Issued During Period Value New Issues | $449.7M | $466.7M | $70.2M | $200.0M | |||
| Due To Related Parties Current | $350.0K | $171.0K | $0.00 | $3.2M | $58.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q4 2020 | Q3 2020 | Q2 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q4 2018 | Q3 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $12.5M | $13.2M | $18.4M | $11.6M | $12.7M | $13.4M | $10.2M | $10.5M | $10.7M | $8.9M | $8.1M | $7.6M | $10.0M | $7.7M | $3.8M | $6.0M | $3.3M | $3.9M | $1.3M | $3.1M | $537.0K | $12.0K | $1.0K | |
| Prepaid Expense Current | $46.8M | $49.7M | $50.9M | $51.7M | $35.6M | $32.6M | $26.6M | $18.8M | $19.8M | $19.2M | $21.1M | $16.5M | $15.9M | $13.5M | $4.8M | $5.8M | $7.0M | $5.9M | $5.8M | $44.0K | $152.1K | $162.1K | ||
| Depreciation | $107.0K | $80.0K | $53.0K | $44.0K | $26.0K | $10.0K | $5.0K | |||||||||||||||||
| Additional Paid In Capital | $2.58B | $2.00B | $1.97B | $1.95B | $1.48B | $1.47B | $1.46B | $1.43B | $950.2M | $939.6M | $920.2M | $840.7M | $832.5M | $812.9M | $802.8M | $594.4M | $584.2M | $577.3M | $385.7M | $182.7M | $4.7M | $4.8M | $24.7K | |
| Foreign Currency Transaction Gain Loss Unrealized | -$571.0K | -$26.0K | $291.0K | |||||||||||||||||||||
| Stock Issued During Period Value New Issues | $543.6M | $466.7M | $70.2M | $200.0M | $0.00 | $0.00 | $9.8M | |||||||||||||||||
| Due To Related Parties Current | $0.00 | $134.0K | $336.0K | $3.1M |
Most recent annual filing with the SEC: May 29, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.